Intrinsically right-handed chiral gold nanoparticles with a multifaceted rhombi cuboctahedral shape deliver siRNA into lung ...

New research shows that gamma irradiation drives p53 wild-type medulloblastoma cells into a senescent state that senolytic ...

Apoptosis is triggered by the activation of Caspases leading to irreversible engagement in cell death. However, recent data outline numerous non-apoptotic functions of caspases as well as quite ...

Loss-of-function mutations in the human OTULIN gene, encoding a deubiquitinase with exclusive specificity for linear ...

Precise spatiotemporal control of protein synthesis is essential during embryogenesis, yet directly measuring translation ...

The FDA’s approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu vaccines. On August 5, the US Food and Drug Administration approved ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Moderna's longtime CEO Stephane Bancel speaks the World Economic Forum in Davos in 2023. Moderna's stock soared Monday after the biotech company confirmed that it will share highly anticipated Phase 3 ...

The treatment can reprogram immune cells that have been corrupted by the cancer, strengthening the body’s ability to attack. Our immune systems don’t just fight bacteria and viruses invading the body.

Moderna’s AI reads a patient’s own tumor, decides which mutations to target and builds a treatment that exists nowhere else. The therapy delivered the first positive Phase 3 result for a cancer ...

The first mRNA flu shot is now available, but not everyone is eligible. Moderna’s mFlusiva is the first flu vaccine in the United States to use messenger RNA technology, the same platform used in ...